ecropolis

TWiV 629: Coronavirus Update + Pandemic Sitrep

Daniel Griffin provides a clinical update on COVID-19, including analysis of the dexamethasone trial, and then the team discusses two Ebolavirus outbreaks in DRC, clinical and virological aspects of asymptomatic SARS-CoV-2 infections, age-dependent effects on transmission, and answer listener email. Hosts: Vincent Racaniello, Dickson Despommier, and Alan Dove. Guests: Daniel Griffin and Chuck Knirsch.

TWiV 629: Coronavirus Update + Pandemic Sitrep Read More »

My patient caught Covid-19 twice. So long to herd immunity hopes?

“Recent reports and conversations with physician colleagues suggest my patient is not alone. Two patients in New Jersey, for instance, appear to have contracted Covid-19 a second time almost two months after fully recovering from their first infection. Daniel Griffin, a physician and researcher at Columbia University in New York, recently described a case of presumed reinfection on the This Week in Virology podcast. “

My patient caught Covid-19 twice. So long to herd immunity hopes? Read More »

The Virus: What Went Wrong?

Our own Dr. Daniel Griffin was featured on Season 2020: Episode 1 of PBS’ long-form news show, FRONTLINE, titled, “The Virus: What Went Wrong?” As COVID-19 spread from Asia to the Middle East to Europe, why was the U.S. caught so unprepared? Despite repeated warnings of a potent contagion headed our way, America’s leaders failed to prepare and protect us. Why and who is accountable? Dr. Griffin is featured just before minute 25.

The Virus: What Went Wrong? Read More »

Support The Foundation for Medical Relief of Children

Throughout the month of July all donations made to Parasites Without Borders will be matched and DOUBLED by PWB and donated to FIMRC’s Project Bududa. Parasites Without Borders is pledging to donate up to $40,000 with a minimum donation of $10,000 automatically given to the Foundation for International Medical Relief of Children.

Support The Foundation for Medical Relief of Children Read More »

July 10, 2020

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings | Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance

July 10, 2020 Read More »

July 3, 2020

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic which has been caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). FDA is committed to providing timely guidance to support response efforts to this pandemic. FDA is issuing this guidance to assist sponsors in the clinical development and licensure of vaccines for the prevention of COVID-19.

July 3, 2020 Read More »

June 26, 2020

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study | Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report | Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes

June 26, 2020 Read More »

June 17, 2020

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series | Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 (Press release) | Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants

June 17, 2020 Read More »

June 11, 2020

COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’ | Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

June 11, 2020 Read More »

June 4, 2020

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | Predicting infectious SARS-CoV-2 from diagnostic samples | Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

June 4, 2020 Read More »

Donate to Parasites Without Borders Today!